BackPraxsyn Overview

Praxsyn Receivables

Latest receivables for PXYN: $11M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$11.06M

Peer average / median

Loading

Praxsyn Receivables History

Loading

Praxsyn vs. peers: Receivables Comparison

Loading

Praxsyn Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Praxsyn (PXYN) FAQ

The latest receivables for PXYN is $11M as of September 2019. Investors often review this figure alongside Praxsyn's historical trend and sector peers before judging valuation or financial health.

A receivables figure of $11M for PXYN is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting PXYN's receivables ($11M), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Praxsyn's receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.